Shenkin Alan
Division of Clinical Chemistry, Faculty of Medicine, University of Liverpool, Liverpool L69 3GA, UK.
Clin Nutr. 2006 Feb;25(1):1-13. doi: 10.1016/j.clnu.2005.11.006. Epub 2006 Jan 10.
Micronutrients play a central role in metabolism and in the maintenance of tissue function, but effects in preventing or treating disease which is not due to micronutrient deficiency cannot be expected from increasing the intake. There is a highly integrated system to control the flux of micronutrients in illness, and this demonstrates just how important the body perceives the micronutrients to be. An adequate intake therefore is necessary to sustain metabolism and tissue function, but provision of excess supplements to individuals who do not need them may be harmful. Clinical benefit is most likely in those individuals who are severely depleted and at risk of complications, and is unlikely if this is not the case. Much more research is needed to characterise better markers of micronutrient status both in terms of metabolic effects and antioxidant effects, so that at-risk patients can be identified and supplementation modified accordingly. Large-scale trials of different doses of micronutrients are required with precise outcome markers to optimise intakes in different groups of patients as well as in the general population.
微量营养素在新陈代谢和维持组织功能方面发挥着核心作用,但不能期望通过增加摄入量来预防或治疗非微量营养素缺乏引起的疾病。在疾病状态下,存在一个高度整合的系统来控制微量营养素的通量,这表明身体认为微量营养素是多么重要。因此,充足的摄入量对于维持新陈代谢和组织功能是必要的,但向不需要的个体提供过量补充剂可能是有害的。临床益处最可能出现在那些严重缺乏微量营养素且有并发症风险的个体中,如果不是这种情况则不太可能出现。需要更多的研究来更好地表征微量营养素状态的代谢效应和抗氧化效应的标志物,以便识别出有风险的患者并相应地调整补充方案。需要进行不同剂量微量营养素的大规模试验,并使用精确的结果标志物,以优化不同患者群体以及普通人群的摄入量。